Your session is about to expire
← Back to Search
Altrazeal (R) Transforming Powder Dressing for Wounds and Injuries
Study Summary
This trial is testing a new burn dressing to see if it's better than the current standard of care.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any vacancies remaining for persons wishing to join this medical experiment?
"The clinicaltrial.gov website confirms that this trial is not actively recruiting patients, despite its original posting on May 26th 2022 and most recent update on June 14th 2022. However, there are 738 other trials still open for enrolment at present."
Does this experiment involve any individuals of advanced age?
"The age range for participants of this clinical trial is 18 to 65. Those outside of the specified boundaries can look into 122 trials tailored towards minors or 590 studies dedicated to senior citizens."
Does Altrazeal (R) Transforming Powder Dressing pose any risks of harm to users?
"Altrazeal (R) Transforming Powder Dressing has been granted approval, thus the safety rating for this product is a 3 on our team's scale."
Are there still opportunities to partake in this medical investigation?
"In order to be considered eligible, the prospective patient should have wounds and fall between ages 18 and 65. Currently, approximately 60 individuals are being recruited for this clinical experiment."
Share this study with friends
Copy Link
Messenger